World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
22248
World Ranking
19794
National Ranking
9857

Edward H. Giannini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward H. Giannini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 184 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edward H. Giannini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward H. Giannini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edward H. Giannini is affiliated with Cincinnati Children's Hospital Medical Center in the United States. Their research spans multiple fields within medicine, with a strong focus on immunology and microbiology. They have contributed extensively to subfields including immunology, oncology, pathology and forensic medicine, epidemiology, and molecular biology.

The scientist's work centers on key topics such as immune cell function and interaction, lymphoma diagnosis and treatment, viral-associated cancers and disorders, T-cell and B-cell immunology, cytomegalovirus and herpesvirus research, systemic lupus erythematosus research, and CAR-T cell therapy research.

Frequent co-authors collaborating with Edward H. Giannini include Jesús Merino, Ester Molina, Lucia García-Gutiérrez, Vanessa Junco, and Mercedes Pérez-Olivares. These collaborations highlight a concentrated effort in immunological and oncological research fields.

Edward H. Giannini has published regularly in several scientific journals. Their frequent publication venues are:

  • Frontiers in Immunology
  • The Journal of Immunology
  • Oncogene
  • Journal for ImmunoTherapy of Cancer
  • Arthritis & Rheumatology

Selected recent papers by Edward H. Giannini include:

  • "Multifaceted effects of soluble human CD6 in experimental cancer models," 2020, Journal for ImmunoTherapy of Cancer
  • "MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells," 2023, Oncogene
  • "CD38 Deficiency Ameliorates Chronic Graft-Versus-Host Disease Murine Lupus via a B-Cell-Dependent Mechanism," 2021, Frontiers in Immunology
  • "Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis," 2020, Arthritis & Rheumatology
  • "INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors," 2023, Blood

Best Publications

  • Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

    Reva C. Lawrence;Charles G. Helmick;Frank C. Arnett;Richard A. Deyo

  • Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Gail D. Cawkwell

  • Preliminary definition of improvement in juvenile arthritis

    Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell

  • Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff

  • Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

    Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz

  • American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

    Carol A. Wallace;Edward H. Giannini;Bin Huang;Lukasz Itert

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

    Daniel J. Lovell;Andreas Reiff;Andreas Reiff;Norman T. Ilowite;Carol A. Wallace

  • Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis

    Carol A. Wallace;Edward H. Giannini;Steven J. Spalding;Philip J. Hashkes;Philip J. Hashkes

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Olcay Y. Jones

  • Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

    Joyce Villanueva;Susan Lee;Edward H Giannini;Thomas B Graham

  • Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function

    Daniel J. Lovell;Carol B. Lindsley;Robert M. Rennebohm;Susan H. Ballinger

  • Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

    Lisa G. Rider;Deloris Koziol;Edward H. Giannini;Minal S. Jain

  • Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury.

    Roger D. Rossen;Judith L. Swain;Lloyd H. Michael;Suzanne Weakley

  • Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

    Carol A. Wallace;Bin Huang;Marcia Bandeira;Angelo Ravelli

  • Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.

    Nicolino Ruperto;Daniel J. Lovell;Pierre Quartier;Eliana Paz

  • Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

    Daniel J. Lovell;Andreas Reiff;Olcay Y. Jones;Rayfel Schneider

  • Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

    Nicolino Ruperto;Angelo Ravelli;Kevin J. Murray;Daniel J. Lovell

  • Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.

    E. H. Giannini;N. T. Ilowite;D. J. Lovell;C. A. Wallace

Frequent Co-Authors

Daniel J. Lovell
Daniel J. Lovell Cincinnati Children's Hospital Medical Center
Nicolino Ruperto
Nicolino Ruperto Istituto Giannina Gaslini
Alberto Martini
Alberto Martini University of Genoa
Angelo Ravelli
Angelo Ravelli University of Genoa
Lisa G. Rider
Lisa G. Rider National Institutes of Health
Lauren M. Pachman
Lauren M. Pachman Northwestern University
Earl D. Silverman
Earl D. Silverman University of Toronto
Frederick W. Miller
Frederick W. Miller National Institutes of Health
Fred D. Finkelman
Fred D. Finkelman University of Cincinnati
Susan D. Thompson
Susan D. Thompson Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible study options, online nursing degrees and related programs offer valuable alternatives. Today, many universities provide pathways that are fully online, making it easier for working professionals or those balancing family commitments.

One popular option is enrolling in most affordable online nurse practitioner programs. These programs allow nurses to expand their qualifications and advance their careers. If you are just beginning your journey, exploring nursing school online can help you start in the healthcare field with convenience and cost-effectiveness.

Nurses aiming for leadership or research positions may consider online PhD programs in nursing, which provide advanced knowledge without the need to relocate or pause your career. Alternatively, registered nurses can upgrade their credentials through what is the cheapest rn to bsn program online options, helping improve their job prospects and earning potential.

Exploring these online degrees gives aspiring healthcare professionals an adaptable route to achieve their career goals in the medical field.

Best Scientists Citing Edward H. Giannini

Trending Scientists

Recently Published Articles